{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T20:48:07Z","timestamp":1775854087521,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"9226","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1016\/s0140-6736(00)02504-6","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T10:52:01Z","timestamp":1027594321000},"page":"291-296","source":"Crossref","is-referenced-by-count":337,"title":["AIDS across Europe, 1994\u201398: the EuroSIDA study"],"prefix":"10.1016","volume":"356","author":[{"given":"A","family":"Mocroft","sequence":"first","affiliation":[]},{"given":"C","family":"Katlama","sequence":"additional","affiliation":[]},{"given":"AM","family":"Johnson","sequence":"additional","affiliation":[]},{"given":"C","family":"Pradier","sequence":"additional","affiliation":[]},{"given":"F","family":"Antunes","sequence":"additional","affiliation":[]},{"given":"F","family":"Mulcahy","sequence":"additional","affiliation":[]},{"given":"A","family":"Chiesi","sequence":"additional","affiliation":[]},{"given":"AN","family":"Phillips","sequence":"additional","affiliation":[]},{"given":"O","family":"Kirk","sequence":"additional","affiliation":[]},{"given":"JD","family":"Lundgren","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(00)02504-6_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0140-6736(95)92649-6","article-title":"Staging system for clinical AIDS patients","volume":"346","author":"Mocroft","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(00)02504-6_bib2","first-page":"624","article-title":"Survival prognosis of HIV\u20101 infected patients","volume":"6","author":"Hanson","year":"1993","journal-title":"J Acquir Immune Defic Syndrome Hum Retrovirol"},{"key":"10.1016\/S0140-6736(00)02504-6_bib3","first-page":"1059","article-title":"The AIDS\u2010defining diagnosis and subsequent complications: a survival based severity index","volume":"4","author":"Turner","year":"1991","journal-title":"J Acquir Immun Defic Syndr Hum Retrovirol"},{"key":"10.1016\/S0140-6736(00)02504-6_bib4","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/infdis\/170.5.1284","article-title":"Incidence of clinical AIDS in a cohort of homosexual men with CD4+ cell counts < 100\/mm3","volume":"170","author":"Bacellar","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/S0140-6736(00)02504-6_bib5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/0003-4819-124-7-199604010-00003","article-title":"Natural history of opportunistic disease in an HIV\u2010infected urban clinical cohort","volume":"124","author":"Moore","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(00)02504-6_bib6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/archinte.158.5.491","article-title":"The incidence of AIDS defining illnesses in 4883 patients with human immunodeficiency virus infection","volume":"158","author":"Mocroft","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0140-6736(00)02504-6_bib7","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archinte.1995.00430140115012","article-title":"Distribution of CD4+ lymphocytes at diagnosis of Acquired Immunodeficiency Syndrome\u2014Defining and other human immunodeficiency virus related illnesses","volume":"155","author":"Hanson","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0140-6736(00)02504-6_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0140-6736(91)91166-R","article-title":"Serial CD4 lymphocyte counts and development of AIDS","volume":"337","author":"Phillips","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(00)02504-6_bib9","first-page":"770","article-title":"Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV\u2010infected persons","volume":"4","author":"Crowe","year":"1991","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/S0140-6736(00)02504-6_bib10","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00002030-199714000-00010","article-title":"Changing incidence of AIDS\u2010defining illnesses in the era of antiretroviral combination therapy","volume":"11","author":"Brodt","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/S0140-6736(00)02504-6_bib11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00042560-199808010-00007","article-title":"Rapid change in the use of antiretroviral agents and improvement in a population of HIV\u2010infected patients: France 1995\u20131997","volume":"18","author":"Spira","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/S0140-6736(00)02504-6_bib12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Paella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(00)02504-6_bib13","doi-asserted-by":"crossref","first-page":"F101","DOI":"10.1097\/00002030-199712000-00003","article-title":"Impact of protease inhibitors on AIDS defining events and hospitalisations in 10 French AIDS reference centres","volume":"11","author":"Mouton","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/S0140-6736(00)02504-6_bib14","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(96)11431-8","article-title":"Cytomegalovirus after initation of highly active antiretroviral therapy","volume":"349","author":"Jacobson","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(00)02504-6_bib15","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/00002030-199814000-00013","article-title":"Opportunistic infections occurring during highly active antiretroviral treatment","volume":"12","author":"Mitchelet","year":"1998","journal-title":"AIDS"},{"issue":"RR10","key":"10.1016\/S0140-6736(00)02504-6_bib16","first-page":"1","article-title":"USPHS\/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: USPHS-IDSA Prevention of Opportunistic Infections Working Group","volume":"48","year":"1999","journal-title":"MWWR"},{"key":"10.1016\/S0140-6736(00)02504-6_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00002030-199902040-00015","article-title":"AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral therapy","volume":"13","author":"Law","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/S0140-6736(00)02504-6_bib18","unstructured":"Egger M. Opportunistic Infections in the era of HAART: 12th World AIDS Conference, Geneva, June 28\u2013July 3, 1998. Abstract 76."},{"key":"10.1016\/S0140-6736(00)02504-6_bib19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00042560-199904150-00017","article-title":"Has the spectrum of AIDS\u2010deining illnesses been changing since the introduction of new treatments and combinations of treatments","volume":"20","author":"Pezzotti","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/S0140-6736(00)02504-6_bib20","unstructured":"Jones J, Hanson D, Dworkin M, Kaplan J. Which opportunistuc illnesses occur in the era of HAART and at ehat CD4 cell counts? 6th Conference on Retrovirus and Opportunistic Infections, Chicago, USA, 1999. Abstract 690."},{"key":"10.1016\/S0140-6736(00)02504-6_bib21","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1086\/515030","article-title":"The incidence and spectrum of AIDS\u2010defining illnesses in person treated with antiretroviral drugs","volume":"27","author":"Forrest","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0140-6736(00)02504-6_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00042560-199711010-00003","article-title":"Regional differences in the use of antiretrovirals and primary prophylaxis in 3122 European HIV\u2010infected patients","volume":"16","author":"Lundgren","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/S0140-6736(00)02504-6_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00042560-199803010-00009","article-title":"Survival in 2367 zidovudine treated patients according to use of other nucleoside analogue drugs","volume":"17","author":"Phillips","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"RR\u201017","key":"10.1016\/S0140-6736(00)02504-6_bib24","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded case definition for AIDS among adolescents and adults","volume":"41","year":"1992","journal-title":"MMWR"},{"key":"10.1016\/S0140-6736(00)02504-6_bib25","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1097\/00002030-199815000-00015","article-title":"Changes in use of antiretroviral therapy in regions of Europe over time","volume":"12","author":"Kirk","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/S0140-6736(00)02504-6_bib26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(98)04954-X","article-title":"Risk of new AIDS diseases in people on triple therapy","volume":"353","author":"Miller","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(00)02504-6_bib27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(97)04161-5","article-title":"Randomised placebo controlled trial of ritonavir in advanced HIV\u20101 disease","volume":"351","author":"Cameron","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(00)02504-6_bib28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trials of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimetre or less","volume":"337","author":"Hammer","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(00)02504-6_bib29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/jama.279.12.930","article-title":"A randomised, double blind trial comparing combinations of nevaripine, didanosine, and zidovudine for HIV\u2010infected patients: the INCAS trial","volume":"279","author":"Montaner","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(00)02504-6_bib30","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(99)03287-0","article-title":"Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV\u20101 infection","volume":"353","author":"Weverling","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(00)02504-6_bib31","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0140-6736(91)91837-K","article-title":"Epstein\u2010Barr virus in AIDS\u2010related primary central nervous system lymphoma","volume":"338","author":"MacMahon","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(00)02504-6_bib32","first-page":"623","article-title":"Pathogenesis of AIDS\u2010related lymphomas: molecular and histogenetic heterogeneity","volume":"152","author":"Gaidano","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/S0140-6736(00)02504-6_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00126334-199908150-00007","article-title":"Changes in AIDS defining illnesses, Royal Free Hospital 1987\u20131998","volume":"21","author":"Mocroft","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/S0140-6736(00)02504-6_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.319.7201.23","article-title":"For the Swiss HIV Cohort Study. Risk of HIV related Kaposi's sarcoma and non\u2010Hodgkins lymphoma with potent antiretroviral therapy.: prospective cohort study","volume":"319","author":"Ledergerber","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(00)02504-6_bib35","first-page":"S11","article-title":"Effect of antiretroviral therapy on recent trends in selected cancers among HIV\u2010infected persons","volume":"21","author":"Jones","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673600025046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673600025046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T12:23:53Z","timestamp":1556799833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673600025046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":35,"journal-issue":{"issue":"9226","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["S0140673600025046"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(00)02504-6","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}